News | May 21, 2010

Delivery System Makes for More Precise Stent Placement

May 21, 2010 – A new stent delivery system is designed to be reliable, easy to use and precise when delivering the self-expanding Supera peripheral vascular stent. The new delivery system was launched this week in Europe.

The Supera Veritas system was developed to deliver the Supera for the treatment of biliary and peripheral artery disease (PAD).

“We have been utilizing the Supera stent clinically for more than two years and we are very impressed with the performance of the stent and positive clinical outcomes,” said Dierk Scheinert, M.D., chairman of the Center for Vascular Medicine at the Park Hospital Leipzig, Germany. "With the new Supera Vertas delivery system, we now have a more effective tool for the smooth and controlled deployment of the Supera stent. It significantly reduces the number of steps needed to prep and deliver the stent, all of which greatly increase its ease of use and accuracy.”

The IDEV Inc. expects to introduce two additional products in its family of Supera stents by the end of this year. The stent uses an interwoven self-expanding nitinol design. It has U.S. Food and Drug Administration (FDA) 510(k) clearance for palliative treatment for biliary strictures produced by malignant neoplasms. It is currently the focus of a prospective, FDA-approved, single-arm clinical trial of 258 patients at up to 40 sites in the United States.

For more information: www.idevtechnologies.com

Related Content

The TIDES-ACS results show us that the Optimax stent is noninferior in patients with acute coronary syndrome compared to Synergy.

The presentation of the ESC late-breaker TIDES-ACS results show us that the Optimax stent is noninferior in patients with acute coronary syndrome compared to Synergy.

News | Stents| November 24, 2017
November 24, 2017 – During a late-breaking session at the European Society of Cardiology (ESC) 2017 meeting, presente
News | Stents| November 10, 2017
Cordis, a Cardinal Health company, recently unveiled a comprehensive interventional cardiology portfolio, which now...
OCT comparison between the Combo vs. Xience stents in the HARMONEE study.

OCT comparison between the Combo vs. Xience stents in the HARMONEE study.

Feature | Stents| November 08, 2017
November 8, 2017 – New results from the HARMONEE Japan/U.S.
FDA Approves COBRA REDUCE Trial of 14-Day DAPT With CeloNova Stent
News | Stents| October 27, 2017
CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of CeloNova's...
CeloNova Cobra Pzf stent
Technology | Stents| March 02, 2017
March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc.
OCT, intravascular imaging, stent, good stent apposition on vessel wall, TRANSFORM-OCT study

An OCT image showing good stent strut apposition against the vessel wall.

News | Stents| January 13, 2017
January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OC
EXCEL Trial, TCT 2016, drug-eluting stents, CABG, surgery left main heart disease, LMCAD

Gregg W. Stone, M.D., presenting the EXCEL data at TCT 2016 during a standing room only late-breaking trial session.

Feature | Stents| January 12, 2017 | Dave Fornell
The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the results
Biotronik's Osiro stent, prison IV trial

Biotronik's Osiro ultra-thin strut, sirolimus-eluting stent.

News | Stents| November 09, 2016
November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin
OCT stent strut coverage

OCT imaging showing neointimal tissue coverage of metallic stent struts.

News | Stents| November 07, 2016
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OC
biosensors Biofreedom stent
News | Stents| November 07, 2016
November 7, 2016 – The two-year results from LEADERS FREE, the first randomized clinical trial dedicated to high blee
Overlay Init